BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19072117)

  • 1. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
    J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
    Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
    Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
    Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry.
    DeSouza LV; Grigull J; Ghanny S; Dubé V; Romaschin AD; Colgan TJ; Siu KW
    Mol Cell Proteomics; 2007 Jul; 6(7):1170-82. PubMed ID: 17374602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
    Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
    J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes in oral squamous cell carcinoma.
    Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
    Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
    Malik UU; Zarina S; Pennington SR
    Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
    Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
    J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed proteins of normal and cancerous human colorectal tissues by liquid chromatograph-mass spectrometer based on iTRAQ approach.
    Lv J; Fan N; Wang Y; Wang X; Gao C
    Cancer Invest; 2015; 33(9):420-8. PubMed ID: 26180943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
    Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
    BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
    Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
    Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
    Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
    J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach.
    Wang R; Yuan Y; Zhou Y; Zhang D; Zhang L; Zeng X; Ji N; Zhou M; Liang X; Chen Y; Geng N; Li J; Chen Q
    Oncol Rep; 2018 Oct; 40(4):2088-2096. PubMed ID: 30066921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.